Overview

Treatment of Heavy and/or Prolonged Menstrual Bleeding Without Organic Cause

Status:
Completed
Trial end date:
2021-02-10
Target enrollment:
Participant gender:
Summary
Abnormal uterine bleeding encompasses abnormalities in the regularity, duration of flow, frequency, and/or blood flow volume relative to normal menstruation. Of these menstrual abnormalities, heavy menstrual bleeding (HMB), defined objectively as a blood loss of 80 ml or more per menstrual cycle , which is unrelated to pregnancy or known pelvic or systemic disease.
Phase:
Phase 3
Details
Lead Sponsor:
Assiut University
Treatments:
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Contraceptive Agents
Contraceptives, Oral
Contraceptives, Oral, Combined
Medroxyprogesterone
Medroxyprogesterone Acetate
Mefenamic Acid
Progesterone